Anti-SLC2A13 (HMIT) (Human) pAb

MBL
Product Code: MBL-BMP026
Product Group: Primary Antibodies
Supplier: MBL
CodeSizePrice
MBL-BMP02650 ul£340.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Isotype: IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Human
Applications:
  • Flow Cytometry
  • Immunocytochemistry (ICC)
  • Immunohistochemistry (IHC)
  • Western Blot (WB)
Shipping:
4°C
Storage:
-20°C

Images

1 / 8
2 / 8
3 / 8
4 / 8
5 / 8
6 / 8
7 / 8
8 / 8

Documents

Further Information

Alternative Names:
HMIT, H+-myo-inositol symport
Applications:
WB - 1:1000 (chemiluminescence detection system) FCM - 1:200 ICC - 1:200 IHC - 1:1000 (Heat treatment required for paraffin)
Background:
SLC2A13, also known as HMIT (H+-myo-inositol symporter), is an odd member of the facilitatative glucose transporter family, as it specifically transports myo-inositol, not hexoses. SLC2A13 is predominantly expressed in astrocytes and neurons in the brain, suggesting that it may be involved in the control of myo-inositol brain metabolism. Dysfunctions or genetic variants of SLC2A13 associated with neuronal disorders have not yet been reported.
Formulation:
50 ul volume of PBS containing50% glycerol, pH 7.2. No preservative is contained.
Gene IDs:
Human: 114134 Mouse: 239606
Immunogen Translated:
Synthetic peptide derived from human SLC2A13
Reactivity:
This antibody can be used to stain endogenous antigen in paraffin embedded human tissues including prostate by immunohistochemistry. The reactivity of this antibody has been confirmed by Western blotting, Immunocytochemistry and intr acellular Flow cytometry to detect the full-length of human SLC2A13 transiently expressed in HEK 293T cells.
Shelf Life:
1 year
Source:
This antibody was affinity purified from rabbit serum. The rabbit was immunized with a synthetic peptide derived from human SLC2A13.
Target:
SLC2A13

References

?1) Uldry, M., et al., EMBO J. 20, 4467-4477 (2001) 2) Bourgeois, F., et al., J. Physiol. 563 , 333-343 (2005)